ORAI1 and pulmonary arterial hypertension: In addition, in PAH-hPECs treated with siOrai2 or siOrai3, we found that CM5480 strongly reduced SOCE, demonstrating that SOCE in PAH-hPECs is mainly due to Orai1 (Supplemental Figure 7, G and H).